Success Stories: NIW Approved in 5 Days, EB1A in Just Over a Month - NAILG Secured Dual Success for Biomedical Postdoctoral Fellow
Client’s Testimonial:
“It has truly been a pleasure working with you, and I greatly appreciate your support and assistance thus far.”
On March 27th, 2024, and April 10th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Postdoctoral Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: Iran
State of Residence at the Time of Filing: Kentucky
Approval Notice Date: : March 27th, 2024 (NIW) and April 10th, 2025 (EB1A)
Processing Time: 5 days (NIW), and 1 month, 6 days (EB1A) (Premium Processing Requested)
Case Summary:
A postdoctoral fellow’s scientific journey is one marked by consistency, depth, and transformative discovery - qualities that made his path from a successful National Interest Waiver (NIW) to an EB1A approval a natural progression. With both petitions prepared and filed by the North America Immigration Law Group (NAILG), our client’s immigration record remains as remarkable as his research portfolio: no Request for Evidence (RFE) issued, and approvals granted without delay.
Over the course of his career, he has carved a distinct place in biomedical science by advancing critical work in molecular microbiology, microbial biotechnology, and tissue engineering. His research led to several pioneering achievements, including the use of halophilic archaea to produce carotenoids, the optimization of extracellular polysaccharide (EPS) applications in wound healing and cancer treatment, and enhancements in the bioactivity of herbal extracts across diverse therapeutic contexts. These contributions have significantly influenced the development of biomaterials and therapeutic strategies within biomedical engineering.
Our client’s impact is measurable, both quantitatively and globally. His scholarly output includes:
• 56 peer-reviewed journal articles, 1 accepted first-authored journal article, 26 abstracts, 2 book chapters
• A total of 1,236 citations, with readers in at least 70 countries, placing him in the top 2% of authors in biomedical engineering.
• He has also demonstrated leadership in academic publishing with 27 completed journal reviews, ensuring the integrity of scientific communication in his field.
In a recommendation supporting his EB1A petition, one expert stated:“[Client]'s work has transformed biomedical science through his findings on fungal EPS. His research encapsulates the present state of the subject through review papers, contributes new knowledge on cultivating EPS from yeast, and illuminates the future of fungal EPS by quantifying the benefits and drawbacks of the practical application of this knowledge into hydrogels. In other words, his work touches upon many aspects of this intricate research area. Collectively, these feats set [client] apart from his peers and render him an invaluable asset to biomedical research in the US.”
NAILG’s team ensured that the petition showcased not only our client’s scientific credentials but also the sustained influence of his work on global biomedical innovation. Their carefully tailored case strategy highlighted the evolution from national interest to extraordinary ability, resulting in another smooth, RFE-free approval. Now, with both NIW and EB1A secured, he continues his work in the United States, where his research supports a healthier, more advanced future in biomedical science.